{"id":"W2015919139","doi":"10.1016/j.ygyno.2009.08.012","title":"A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Queen's University; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Sunitinib; Internal medicine; Sunitinib malate; Discontinuation; Clinical endpoint; Oncology; Cervical cancer; Vascular endothelial growth factor; Phases of clinical research; Gastroenterology; Urology; Surgery; Renal cell carcinoma; Cancer; Chemotherapy; Clinical trial; VEGF receptors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007838002,0.001022787,0.001573049,0.0003969033,0.0004303874,0.0006264861,0.0005838452,0.001166873,0.008239339],"category_scores_gemma":[0.0007323139,0.0002713576,0.001141716,0.0004109373,0.0005567,0.000635756,0.000254006,0.002468228,0.001022107],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007788019,"about_ca_system_score_gemma":0.001326294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001956985,"about_ca_topic_score_gemma":0.007203517,"domain_scores_codex":[0.9998015,0.0001003545,0.000007116922,0.00002743673,0.00001698924,0.00004658535],"domain_scores_gemma":[0.9996387,0.00007777645,0.00005223417,0.00002621652,0.00002008285,0.0001849583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.758331,0.02128538,0.005661438,0.002283445,0.002414524,0.0003390316,0.0002724816,0.003774519,0.01842674,0.0007880946,0.02410937,0.162314],"study_design_scores_gemma":[0.7973288,0.1789206,0.0112146,0.0000872548,0.0007478044,0.0002971769,0.00008284709,0.001370196,0.001631936,0.0004686907,0.007813639,0.00003653236],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9735066,0.007421704,0.0005565519,0.001887082,0.0003860072,0.003709811,0.003996901,0.0002202698,0.008315113],"genre_scores_gemma":[0.9786854,0.003838371,0.001196707,0.001977882,0.0002723303,0.00234951,0.00356183,0.00004437211,0.008073619],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008239339,"threshold_uncertainty_score":0.02756327,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0431346468928451,"score_gpt":0.3605023068420973,"score_spread":0.3173676599492523,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}